Delivery Order SPE2DR25D2011-SPE2DR26FADTL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Lyrica 150 mg capsules (90-count units) valued at $1,723.91. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by December 31, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,164.40 to AmerisourceBergen Drug Corp for the supply of Lyrica 150 mg capsules (90-count unit) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,866.31 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules in unit dose packaging (100 count). The contract, awarded on January 12, 2026, with an ultimate completion date of January 13, 2026, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a $2,336.03 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Lyrica 100 mg capsules (90-count units). This competitively awarded contract utilizes firm fixed pricing and is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,119.78 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) on December 16, 2025, with completion expected by December 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds...
- The Defense Logistics Agency awarded a $3,322.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lyrica 75 mg capsules in unit dose packaging (100 count) on December 18, 2025, with completion scheduled for December 19, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime contractor, headquartered in...
- The Defense Logistics Agency awarded a $1,196.02 firm fixed-price delivery order to Amerisourcebergen Drug Corp on January 7, 2026, for the supply of Lyrica 75 mg capsules (90 count). This non-set-aside contract represents a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,240.63 to AmerisourceBergen Drug Corp for the supply of Lyrica 225 mg capsules (90-count units). This firm fixed-price delivery order, awarded on December 11, 2025, with completion targeted for December 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded without set-aside designation and will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,580.34 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units). This firm fixed price, competitively awarded contract was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,196.02 to AmerisourceBergen Drug Corp for the supply of Lyrica 75 mg capsules (90-count units). The contract, awarded on January 8, 2026, with an ultimate completion date of January 9, 2026, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this order. The company is a subsidiary of Cencora, Inc., a major...
- SPE2DR25D2011Indefinite Delivery Contract
- SPE2DR25D2011-SPE2DR26FADTLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,195.56 to AmerisourceBergen Drug Corp for the supply of Lyrica 150 mg capsules (90-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price, non-set-aside contract is performed at the awardee's location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary procurement vehicle for pharmaceutical products and medical supplies supporting military healthcare programs globally. AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor within the federal medical supply chain, delivering brand-name and generic medications across multiple therapeutic domains to military and veteran healthcare systems. The Lyrica supply fulfills neurological treatment needs within the Defense Health Agency's medical supply requirements. As a subsidiary of Cencora, Inc., which competes on a full and open basis for federal procurement, AmerisourceBergen has demonstrated consistent capability in executing firm fixed-price delivery orders ranging from minimal to substantial values, enabling the agency to efficiently procure essential pharmaceutical commodities required by military treatment facilities and federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/11/26 |